Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodelglitazar Dose-Ranging Study in Type 2 Diabetes Mellitus
NCT00196989Phase 2Completed
- Sponsor
- GSK
- Start
- Sep 2005
- Primary completion
- Apr 2007
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 2 trial of saroglitazar in type 2 diabetes mellitus (T2DM), sponsored by GSK. Started Sep 2005; status: completed.
02
Drugs
saroglitazar
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00196989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00196989.